It will be important to investigate whether the IgM-expressing fraction of atMBC in CHB can synthesize Abs with pathogenic potential, as previously ascribed to intrahepatic IgM+anti-HBc Abs in HBV-associated acute liver failure (70). Here, KRT88P is linked to acute liver failure.